33 New York Ave
Update
07/03/18
Replimune Signs Lease at 33 New York Ave, Framingham
King Street Properties plan to transform the former Metro West's Newspaper building into a life science hub is in full swing and they have signed on the startup Replimune as a new tenant. Replimune, who recently filed a $100 million IPO, is developing oncolytic immunotherapies to fight solid tumors.
The Framingham property is undergoing renovations and expansion including additional parking, new pedestrian walkways, and new landscaping.